Ligand · LBD
LBD · N-(3-tert-butyl-1H-pyrazol-5-yl)-2-[(2R)-2-methylpiperazin-1-yl]quinazolin-4-amine
LBD, N-(3-tert-butyl-1H-pyrazol-5-yl)-2-[(2R)-2-methylpiperazin-1-yl]quinazolin-4-amine (C20 H27 N7, 365.5 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site with its residues within 4.5 Å…
- Component
- LBD
- Formula
- C20 H27 N7
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
LBD in 2 structures; the first of them:
- 6NYV · Structure of spastin AAA domain in complex with a quinazoline-based inhibitor · LBD B802 · binds ASP484, ILE485, ALA486, GLY487, GLN488, GLY526, ASN527, GLY528 and 8 more
- 6NYV · Structure of spastin aaa domain in complex with a quinazoline-based inhibitor · LBD B802 · binds ASP484, ILE485, ALA486, GLY487, GLN488, GLY526, ASN527, GLY528 and 8 more
Residues it binds most
GLY 2, LEU 2, SER 2, THR 2, ALA 2, ASN 2, ASP 2, GLN 2, ILE 2, PRO 2 (residue and the binding sites it lines).
Found with
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.